HIV Clinical Trial
Official title:
Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women
The purpose of this study is to test the efficacy of an innovative, culturally relevant, community-based peer group intervention to increase young rural Malawian women's preconception behaviors to optimize their reproductive health. The study uses a longitudinal, two group (two-arm) design with a delayed control group.
Maintaining optimal reproductive health in the context of high HIV prevalence is a serious
dilemma facing young women in Malawi and other high HIV prevalence countries. Optimal
reproductive health requires practicing preconception behaviors to promote overall health
including avoiding HIV infection. These healthy preconception behaviors include: practicing
safer sex (abstaining or using condoms) to prevent sexually transmitted infections (STIs),
including HIV infection; obtaining treatment for STIs; maintaining good health habits such
as diet, exercise and avoiding substance use; using an effective family planning method to
prevent unintended pregnancy; and having an HIV test periodically and with the partner when
conception is intended. However the Malawi Demographic and Health Survey provides evidence
that few women ages 15-20 in Malawi currently practice these healthy preconception
behaviors. Currently, no programs in Malawi offer an integrated approach to optimal
reproductive health.
To fill this gap, this study developed an innovative, culturally relevant, community-based
peer group intervention to increase young rural Malawian women's preconception behaviors to
optimize their reproductive health. The intervention is called Mzanga Samala Moyo Wako
([Mzanga] Sharing Responsibility for Pregnancy Planning and HIV Prevention). Mzanga builds
on the investigators' previous research in Malawi, which tested a culturally relevant HIV
prevention peer group intervention that changed HIV prevention-related knowledge, attitudes,
and safer sex behaviors for rural adults and adolescents. This study integrated that prior
HIV prevention content with new content on maintaining health, family planning, and
preconception HIV testing.
The purpose of this study is to test Mzanga's efficacy using a longitudinal, two group (two
arm) design: intervention group and delayed control group. Because Mzanga is expected to
diffuse widely, we randomize at the community rather than the individual level. Eighteen
geographically separate rural communities stratified by size and distance from the main
paved road and then randomly assigned to Mzanga or the delayed control condition. We
implement Mzanga in 9 waves. A final sample of 345 per group after attrition provides
adequate power (80%) to detect small-to-medium effects. After baseline data collection, the
Mzanga group receives the eight-session intervention. Outcomes are measured at 9 months
post-baseline (6 months post-intervention), followed by a booster session for the Mzanga
group, and final evaluation at 15 months post-baseline. After the 15-month data collection,
Mzanga is offered to the delayed control group.
The study aims and hypotheses are:
Aim 1. To test the efficacy of the Mzanga intervention for improving reproductive health
outcome mediating and behavioral variables for Malawian rural young women at 9 and 15 months
post-baseline.
H1.Controlling for baseline differences and group effects, compared to the delayed control
group, the intervention group will show more positive mediating and behavioral outcomes:
1. Practice safer sex,
2. Obtain prompt treatment for STI symptoms;
3. Maintain good health habits (diet, exercise, substance use);
4. Use an effective family planning method except when pregnancy is intended;
5. Have an HIV test periodically, with partner when conception is intended; and
6. More positive scores for the mediating variables of knowledge, attitudes, perceived
norms, self-efficacy, and intentions for each of these behaviors.
Aim 2. To test a theoretical model of the mechanisms through which the Mzanga intervention
changes preconception health behaviors of young women in rural Malawi.
H2. Mzanga's effects on healthy preconception behaviors (a-e above) will be mediated by
knowledge, attitudes, perceived norms, self-efficacy, and intention scores.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |